Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup .

Infection and immunity

Chaand M, Miller KA, Sofia MK, Schlesener C, Weaver JW, Sood V, Dziejman M.
PMID: 25939511
Infect Immun. 2015 Jul;83(7):2862-2869. doi: 10.1128/IAI.03020-14. Epub 2015 May 04.

Vibrio cholerae is a genetically diverse species, and pathogenic strains can encode different virulence factors that mediate colonization and secretory diarrhea. Although the toxin co-regulated pilus (TCP) is the primary colonization factor in epidemic causing V. cholerae strains, other...

Cite
Chaand M, Miller KA, Sofia MK, et al. Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup . Infect Immun. 2015;83(7):2862-2869doi: 10.1128/IAI.03020-14.
Chaand, M., Miller, K. A., Sofia, M. K., Schlesener, C., Weaver, J. W., Sood, V., & Dziejman, M. (2015). Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup . Infection and immunity, 83(7), 2862-2869. https://doi.org/10.1128/IAI.03020-14
Chaand, Mudit, et al. "Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup ." Infection and immunity vol. 83,7 (2015): 2862-2869. doi: https://doi.org/10.1128/IAI.03020-14
Chaand M, Miller KA, Sofia MK, Schlesener C, Weaver JW, Sood V, Dziejman M. Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup . Infect Immun. 2015 Jul;83(7):2862-2869. doi: 10.1128/IAI.03020-14. Epub 2015 May 04. PMID: 25939511; PMCID: PMC4468554.
Copy Download .nbib Format: NLM
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform.

Frontiers in microbiology

Dai T, Fuchs BB, Coleman JJ, Prates RA, Astrakas C, St Denis TG, Ribeiro MS, Mylonakis E, Hamblin MR, Tegos GP.
PMID: 22514547
Front Microbiol. 2012 Apr 10;3:120. doi: 10.3389/fmicb.2012.00120. eCollection 2012.

Opportunistic fungal pathogens may cause superficial or serious invasive infections, especially in immunocompromised and debilitated patients. Invasive mycoses represent an exponentially growing threat for human health due to a combination of slow diagnosis and the existence of relatively few...

Cite
Dai T, Fuchs BB, Coleman JJ, et al. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol. 2012;3:120doi: 10.3389/fmicb.2012.00120.
Dai, T., Fuchs, B. B., Coleman, J. J., Prates, R. A., Astrakas, C., St Denis, T. G., Ribeiro, M. S., Mylonakis, E., Hamblin, M. R., & Tegos, G. P. (2012). Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Frontiers in microbiology, 3120. https://doi.org/10.3389/fmicb.2012.00120
Dai, Tianhong, et al. "Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform." Frontiers in microbiology vol. 3 (2012): 120. doi: https://doi.org/10.3389/fmicb.2012.00120
Dai T, Fuchs BB, Coleman JJ, Prates RA, Astrakas C, St Denis TG, Ribeiro MS, Mylonakis E, Hamblin MR, Tegos GP. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol. 2012 Apr 10;3:120. doi: 10.3389/fmicb.2012.00120. eCollection 2012. PMID: 22514547; PMCID: PMC3322354.
Copy Download .nbib Format: NLM
Macrophage .

Current fungal infection reports

Mansour MK, Reedy JL, Tam JM, Vyas JM.
PMID: 24660045
Curr Fungal Infect Rep. 2014 Mar 01;8(1):109-115. doi: 10.1007/s12281-013-0165-7.

No abstract available.

Cite
Mansour MK, Reedy JL, Tam JM, et al. Macrophage . Curr Fungal Infect Rep. 2014;8(1):109-115doi: 10.1007/s12281-013-0165-7.
Mansour, M. K., Reedy, J. L., Tam, J. M., & Vyas, J. M. (2014). Macrophage . Current fungal infection reports, 8(1), 109-115. https://doi.org/10.1007/s12281-013-0165-7
Mansour, Michael K, et al. "Macrophage ." Current fungal infection reports vol. 8,1 (2014): 109-115. doi: https://doi.org/10.1007/s12281-013-0165-7
Mansour MK, Reedy JL, Tam JM, Vyas JM. Macrophage . Curr Fungal Infect Rep. 2014 Mar 01;8(1):109-115. doi: 10.1007/s12281-013-0165-7. PMID: 24660045; PMCID: PMC3958962.
Copy Download .nbib Format: NLM
Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function.

Science advances

Sen P, Wilkie AR, Ji F, Yang Y, Taylor IJ, Velazquez-Palafox M, Vanni EAH, Pesola JM, Fernandez R, Chen H, Morsett LM, Abels ER, Piper M, Lane RJ, Hickman SE, Means TK, Rosenberg ES, Sadreyev RI, Li B, Coen DM, Fishman JA, El Khoury J.
PMID: 32494628
Sci Adv. 2020 Apr 22;6(17):eaax9856. doi: 10.1126/sciadv.aax9856. eCollection 2020 Apr.

Cytomegalovirus (CMV) is an important cause of morbidity and mortality in the immunocompromised host. In transplant recipients, a variety of clinically important "indirect effects" are attributed to immune modulation by CMV, including increased mortality from fungal disease, allograft dysfunction...

Cite
Sen P, Wilkie AR, Ji F, et al. Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function. Sci Adv. 2020;6(17):eaax9856doi: 10.1126/sciadv.aax9856.
Sen, P., Wilkie, A. R., Ji, F., Yang, Y., Taylor, I. J., Velazquez-Palafox, M., Vanni, E. A. H., Pesola, J. M., Fernandez, R., Chen, H., Morsett, L. M., Abels, E. R., Piper, M., Lane, R. J., Hickman, S. E., Means, T. K., Rosenberg, E. S., Sadreyev, R. I., Li, B., Coen, D. M., Fishman, J. A., & El Khoury, J. (2020). Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function. Science advances, 6(17), eaax9856. https://doi.org/10.1126/sciadv.aax9856
Sen, Pritha, et al. "Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function." Science advances vol. 6,17 (2020): eaax9856. doi: https://doi.org/10.1126/sciadv.aax9856
Sen P, Wilkie AR, Ji F, Yang Y, Taylor IJ, Velazquez-Palafox M, Vanni EAH, Pesola JM, Fernandez R, Chen H, Morsett LM, Abels ER, Piper M, Lane RJ, Hickman SE, Means TK, Rosenberg ES, Sadreyev RI, Li B, Coen DM, Fishman JA, El Khoury J. Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function. Sci Adv. 2020 Apr 22;6(17):eaax9856. doi: 10.1126/sciadv.aax9856. eCollection 2020 Apr. PMID: 32494628; PMCID: PMC7176434.
Copy Download .nbib Format: NLM
GPS-estimated foot traffic data and venue selection for COVID-19 serosurveillance studies.

medRxiv : the preprint server for health sciences

Brown TS, de Salazar Munoz PM, Bhatia A, Bunda B, Williams EK, Bor D, Miller JS, Mohareb A, Naranbai V, Beltran WG, Miller TE, Thierauf J, Yang W, Kress D, Stelljes K, Johnson K, Larremore DB, Lennerz J, Iafrate AJ, Balsari S, Buckee CO, Grad YH.
PMID: 33564784
medRxiv. 2021 Feb 05; doi: 10.1101/2021.02.03.21251011.

Tracking the dynamics and spread of COVID-19 is critical to mounting an effective response to the pandemic. In the absence of randomized representative serological surveys, many SARS-CoV-2 serosurveillance studies have relied on convenience sampling to estimate cumulative incidence. One...

Cite
Brown TS, de Salazar Munoz PM, Bhatia A, et al. GPS-estimated foot traffic data and venue selection for COVID-19 serosurveillance studies. medRxiv. 2021;doi: 10.1101/2021.02.03.21251011.
Brown, T. S., de Salazar Munoz, P. M., Bhatia, A., Bunda, B., Williams, E. K., Bor, D., Miller, J. S., Mohareb, A., Naranbai, V., Beltran, W. G., Miller, T. E., Thierauf, J., Yang, W., Kress, D., Stelljes, K., Johnson, K., Larremore, D. B., Lennerz, J., Iafrate, A. J., Balsari, S., Buckee, C. O., & Grad, Y. H. (2021). GPS-estimated foot traffic data and venue selection for COVID-19 serosurveillance studies. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.02.03.21251011
Brown, Tyler S, et al. "GPS-estimated foot traffic data and venue selection for COVID-19 serosurveillance studies." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.02.03.21251011
Brown TS, de Salazar Munoz PM, Bhatia A, Bunda B, Williams EK, Bor D, Miller JS, Mohareb A, Naranbai V, Beltran WG, Miller TE, Thierauf J, Yang W, Kress D, Stelljes K, Johnson K, Larremore DB, Lennerz J, Iafrate AJ, Balsari S, Buckee CO, Grad YH. GPS-estimated foot traffic data and venue selection for COVID-19 serosurveillance studies. medRxiv. 2021 Feb 05; doi: 10.1101/2021.02.03.21251011. PMID: 33564784; PMCID: PMC7872379.
Copy Download .nbib Format: NLM
Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB.

mBio

Chen P, Russo BC, Duncan-Lowey JK, Bitar N, Egger KT, Goldberg MB.
PMID: 34809452
mBio. 2021 Dec 21;12(6):e0302121. doi: 10.1128/mBio.03021-21. Epub 2021 Nov 23.

No abstract available.

Cite
Chen P, Russo BC, Duncan-Lowey JK, et al. Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio. 2021;12(6):e0302121doi: 10.1128/mBio.03021-21.
Chen, P., Russo, B. C., Duncan-Lowey, J. K., Bitar, N., Egger, K. T., & Goldberg, M. B. (2021). Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio, 12(6), e0302121. https://doi.org/10.1128/mBio.03021-21
Chen, Poyin, et al. "Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB." mBio vol. 12,6 (2021): e0302121. doi: https://doi.org/10.1128/mBio.03021-21
Chen P, Russo BC, Duncan-Lowey JK, Bitar N, Egger KT, Goldberg MB. Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio. 2021 Dec 21;12(6):e0302121. doi: 10.1128/mBio.03021-21. Epub 2021 Nov 23. PMID: 34809452; PMCID: PMC8609354.
Copy Download .nbib Format: NLM
Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB.

mBio

Chen P, Russo BC, Duncan-Lowey JK, Bitar N, Egger KT, Goldberg MB.
PMID: 34809452
mBio. 2021 Nov 23;e0302121. doi: 10.1128/mBio.03021-21. Epub 2021 Nov 23.

No abstract available.

Cite
Chen P, Russo BC, Duncan-Lowey JK, et al. Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio. 2021;e0302121doi: 10.1128/mBio.03021-21.
Chen, P., Russo, B. C., Duncan-Lowey, J. K., Bitar, N., Egger, K. T., & Goldberg, M. B. (2021). Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio, e0302121. https://doi.org/10.1128/mBio.03021-21
Chen, Poyin, et al. "Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB." mBio vol. (2021): e0302121. doi: https://doi.org/10.1128/mBio.03021-21
Chen P, Russo BC, Duncan-Lowey JK, Bitar N, Egger KT, Goldberg MB. Topology and Contribution to the Pore Channel Lining of Plasma Membrane-Embedded Shigella flexneri Type 3 Secretion Translocase IpaB. mBio. 2021 Nov 23;e0302121. doi: 10.1128/mBio.03021-21. Epub 2021 Nov 23. PMID: 34809452; PMCID: PMC8609354.
Copy Download .nbib Format: NLM
Evolution and emergence of multidrug-resistant .

Microbial genomics

Brown TS, Eldholm V, Brynildsrud O, Osnes M, Levy N, Stimson J, Colijn C, Alexandru S, Noroc E, Ciobanu N, Crudu V, Cohen T, Mathema B.
PMID: 34431762
Microb Genom. 2021 Aug;7(8). doi: 10.1099/mgen.0.000620.

The evolution and emergence of drug-resistant tuberculosis (TB) has been studied extensively in some contexts, but the ecological drivers of these two processes remain poorly understood. This study sought to describe the joint evolutionary and epidemiological histories of a...

Cite
Brown TS, Eldholm V, Brynildsrud O, et al. Evolution and emergence of multidrug-resistant . Microb Genom. 2021;7(8)doi: 10.1099/mgen.0.000620.
Brown, T. S., Eldholm, V., Brynildsrud, O., Osnes, M., Levy, N., Stimson, J., Colijn, C., Alexandru, S., Noroc, E., Ciobanu, N., Crudu, V., Cohen, T., & Mathema, B. (2021). Evolution and emergence of multidrug-resistant . Microbial genomics, 7(8), . https://doi.org/10.1099/mgen.0.000620
Brown, Tyler S, et al. "Evolution and emergence of multidrug-resistant ." Microbial genomics vol. 7,8 (2021). doi: https://doi.org/10.1099/mgen.0.000620
Brown TS, Eldholm V, Brynildsrud O, Osnes M, Levy N, Stimson J, Colijn C, Alexandru S, Noroc E, Ciobanu N, Crudu V, Cohen T, Mathema B. Evolution and emergence of multidrug-resistant . Microb Genom. 2021 Aug;7(8). doi: 10.1099/mgen.0.000620. PMID: 34431762; PMCID: PMC8549355.
Copy Download .nbib Format: NLM
Fecal microbiota transplant: benefits and risks.

Open forum infectious diseases

Weil AA, Hohmann EL.
PMID: 26034756
Open Forum Infect Dis. 2015 Feb 04;2(1):ofv005. doi: 10.1093/ofid/ofv005. eCollection 2015 Jan.

No abstract available.

Cite
Weil AA, Hohmann EL. Fecal microbiota transplant: benefits and risks. Open Forum Infect Dis. 2015;2(1):ofv005doi: 10.1093/ofid/ofv005.
Weil, A. A., & Hohmann, E. L. (2015). Fecal microbiota transplant: benefits and risks. Open forum infectious diseases, 2(1), ofv005. https://doi.org/10.1093/ofid/ofv005
Weil, Ana A, and Hohmann, Elizabeth L. "Fecal microbiota transplant: benefits and risks." Open forum infectious diseases vol. 2,1 (2015): ofv005. doi: https://doi.org/10.1093/ofid/ofv005
Weil AA, Hohmann EL. Fecal microbiota transplant: benefits and risks. Open Forum Infect Dis. 2015 Feb 04;2(1):ofv005. doi: 10.1093/ofid/ofv005. eCollection 2015 Jan. PMID: 26034756; PMCID: PMC4438886.
Copy Download .nbib Format: NLM
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response.

Nature communications

Herman JD, Wang C, Loos C, Yoon H, Rivera J, Eugenia Dieterle M, Haslwanter D, Jangra RK, Bortz RH, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G.
PMID: 34824251
Nat Commun. 2021 Nov 25;12(1):6853. doi: 10.1038/s41467-021-27201-y.

Transfer of convalescent plasma (CP) had been proposed early during the SARS-CoV-2 pandemic as an accessible therapy, yet trial results worldwide have been mixed, potentially due to the heterogeneous nature of CP. Here we perform deep profiling of SARS-CoV-2-specific...

Cite
Herman JD, Wang C, Loos C, et al. Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nat Commun. 2021;12(1):6853doi: 10.1038/s41467-021-27201-y.
Herman, J. D., Wang, C., Loos, C., Yoon, H., Rivera, J., Eugenia Dieterle, M., Haslwanter, D., Jangra, R. K., Bortz, R. H., Bar, K. J., Julg, B., Chandran, K., Lauffenburger, D., Pirofski, L. A., & Alter, G. (2021). Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nature communications, 12(1), 6853. https://doi.org/10.1038/s41467-021-27201-y
Herman, Jonathan D, et al. "Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response." Nature communications vol. 12,1 (2021): 6853. doi: https://doi.org/10.1038/s41467-021-27201-y
Herman JD, Wang C, Loos C, Yoon H, Rivera J, Eugenia Dieterle M, Haslwanter D, Jangra RK, Bortz RH, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G. Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nat Commun. 2021 Nov 25;12(1):6853. doi: 10.1038/s41467-021-27201-y. PMID: 34824251; PMCID: PMC8617042.
Copy Download .nbib Format: NLM
Subacute Bacterial Endocarditis with .

Case reports in infectious diseases

Matias WR, Bourque DL, Niwano T, Onderdonk AB, Katz JT.
PMID: 27895947
Case Rep Infect Dis. 2016;2016:3051212. doi: 10.1155/2016/3051212. Epub 2016 Nov 08.

No abstract available.

Cite
Matias WR, Bourque DL, Niwano T, et al. Subacute Bacterial Endocarditis with . Case Rep Infect Dis. 2016;2016:3051212doi: 10.1155/2016/3051212.
Matias, W. R., Bourque, D. L., Niwano, T., Onderdonk, A. B., & Katz, J. T. (2016). Subacute Bacterial Endocarditis with . Case reports in infectious diseases, 20163051212. https://doi.org/10.1155/2016/3051212
Matias, Wilfredo R, et al. "Subacute Bacterial Endocarditis with ." Case reports in infectious diseases vol. 2016 (2016): 3051212. doi: https://doi.org/10.1155/2016/3051212
Matias WR, Bourque DL, Niwano T, Onderdonk AB, Katz JT. Subacute Bacterial Endocarditis with . Case Rep Infect Dis. 2016;2016:3051212. doi: 10.1155/2016/3051212. Epub 2016 Nov 08. PMID: 27895947; PMCID: PMC5118523.
Copy Download .nbib Format: NLM
The starting lineup: key microbial players in intestinal immunity and homeostasis.

Frontiers in microbiology

Reading NC, Kasper DL.
PMID: 21779278
Front Microbiol. 2011 Jul 07;2:148. doi: 10.3389/fmicb.2011.00148. eCollection 2011.

The complexity of microbiota inhabiting the intestine is increasingly apparent. Delicate balance of numerous bacterial species can affect development of the immune system, how susceptible a host is to pathogenic organisms, and the auto-inflammatory state of the host. In...

Cite
Reading NC, Kasper DL. The starting lineup: key microbial players in intestinal immunity and homeostasis. Front Microbiol. 2011;2:148doi: 10.3389/fmicb.2011.00148.
Reading, N. C., & Kasper, D. L. (2011). The starting lineup: key microbial players in intestinal immunity and homeostasis. Frontiers in microbiology, 2148. https://doi.org/10.3389/fmicb.2011.00148
Reading, Nicola C, and Kasper, Dennis L. "The starting lineup: key microbial players in intestinal immunity and homeostasis." Frontiers in microbiology vol. 2 (2011): 148. doi: https://doi.org/10.3389/fmicb.2011.00148
Reading NC, Kasper DL. The starting lineup: key microbial players in intestinal immunity and homeostasis. Front Microbiol. 2011 Jul 07;2:148. doi: 10.3389/fmicb.2011.00148. eCollection 2011. PMID: 21779278; PMCID: PMC3133820.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries